Cita APA (7a ed.)

Sasipong, N. (2019). Targeted overexpression of relaxin receptor 1 (RXFP1) with chronic administration of relaxin as a novel inotropic approach for heart failure treatment.

Cita Chicago Style (17a ed.)

Sasipong, Nuttarak. Targeted Overexpression of Relaxin Receptor 1 (RXFP1) with Chronic Administration of Relaxin as a Novel Inotropic Approach for Heart Failure Treatment. Heidelberg, 2019.

Cita MLA (9a ed.)

Sasipong, Nuttarak. Targeted Overexpression of Relaxin Receptor 1 (RXFP1) with Chronic Administration of Relaxin as a Novel Inotropic Approach for Heart Failure Treatment. 2019.